Header Logo

Connection

DAVID POPLACK to Antineoplastic Agents, Alkylating

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Antineoplastic Agents, Alkylating.
DAVID POPLACK
Connection Strength
0.031
Antineoplastic Agents, Alkylating
  1. A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Invest New Drugs. 1996; 13(4):337-42.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.